Deep EigenMatics Tops 2025 Global AI Drug Discovery Patent Rankings

Feb 4, 2026
Deep EigenMatics has secured the top global ranking for new U.S. patent families in AI drug discovery methods for 2025, surpassing all major pharmaceutical companies in patent output during its first year of operation.

Deep EigenMatics has achieved the number one global ranking for new U.S. patent families in AI drug discovery methods for 2025, announced in a press release. The company, which began operations in 2025, secured four unique patent families covering its proprietary computational architectures for exploring chemical space.

The patents represent twice the combined output of all major pharmaceutical companies in the same category. Deep EigenMatics measured its performance using two internal metrics—Patent Family Volume and Innovation Velocity Index—indicating a high efficiency rate in its R&D operations.

Building on this momentum, the company has identified the Oral GLP-1 category as its lead therapeutic target. It plans to move into the execution phase for its Oral GLP-1 candidate, with a development roadmap extending through 2026 and 2027.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.